FDA Inspection 1276846 — DOH Central Pharmacy
The FDA completed an inspection of DOH Central Pharmacy on July 28, 2025 in Tallahassee, FL. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 6 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- July 28, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Tallahassee, FL (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 1105 | 21 CFR 211.22(d) | Procedures not in writing, fully followed |
| 1767 | 21 CFR 211.137(a) | Expiration date lacking |
| 1802 | 21 CFR 211.84(b) | Representative Samples |
| 1975 | 21 CFR 211.182 | Written records kept in individual logs |
| 2618 | 21 CFR 211.198(b)(1) | Complaint Record required information |
| 3629 | 21 CFR 211.170(b) | Reserve samples identified, representative, stored |